Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
Recursion is headquartered in Salt Lake City with offices in Toronto, Montréal, London, and the San Francisco Bay Area. Learn more at www.Recursion.com.
Shared 1 week ago
272 views
How We're Leveraging AI to Address Key Pain Points in Drug Discovery -- Najat Khan, PhD on Bloomberg
Shared 1 week ago
782 views
Shared 1 week ago
886 views
Shared 1 month ago
391 views
Shared 1 month ago
371 views
Shared 3 months ago
712 views
Shared 4 months ago
3.3K views
Shared 7 months ago
3.1K views
Shared 7 months ago
1.2K views
Shared 7 months ago
988 views
Shared 7 months ago
421 views
Shared 7 months ago
987 views
Shared 7 months ago
602 views
Shared 7 months ago
479 views
Shared 7 months ago
367 views
Shared 7 months ago
35K views
Shared 10 months ago
130 views
Shared 11 months ago
50K views
Shared 1 year ago
1.7K views
Shared 1 year ago
496 views
Shared 1 year ago
300 views
Explore Recursion’s Mapping & Navigating Technologies - Imran Haque, Senior VP AI & Digital Sciences
Shared 1 year ago
3.1K views
Shared 1 year ago
1.5K views
Shared 1 year ago
547 views
Shared 1 year ago
650 views
Shared 1 year ago
2.6K views
Shared 1 year ago
433 views
Shared 1 year ago
2.6K views
Download Day 2023 — Preclinical Opportunities with Laura Schaevitz, Recursion SVP & Head of Research
Shared 1 year ago
557 views
Shared 1 year ago
248 views
Shared 1 year ago
1K views